QT prolongation associated with the use of anti-epileptic drugs (AEDs)

Cardio Debate > Cardio Notes > QT prolongation associated with the use of anti-epileptic drugs (AEDs)

Part of: NEUROCARDIOLOGY - EPILEPSY AND CARDIOVASCULAR DISEASE

This educational programme focuses on putative mechanistic links between epilepsy and cardiovascular disease, raises clinically relevant questions about anti-epileptic drug use in the context of cardiac disease, and addresses unresolved issues of practical importance in this area of “neuro-cardiology”.

09/02/2015 - Sudden unexpected death in epilepsy (SUDEP): What is the cause? -

09/02/2015 - Long QT syndrome and epilepsy -

09/02/2015 - Poorer clinical outcome in seizure-related “takotsubo syndrome”. -

09/02/2015 - Distinguishing between epileptic seizures and cardiac syncope -

06/26/2015 - Management of angina and the role of Ranolazine in the context of the NICE guidelines -

06/26/2015 - Clinical cases where an indication for ranolazine may exist - Dr Rajan Sharma, St Geroge's University of London

06/26/2015 - Antianginal agents: Beneficial effects of Ranolazine -

06/26/2015 - Antianginal agents: Prescribing in real life clinical practice -

06/26/2015 - Guidelines (ESC & NICE) for the pharmacological management of angina pectoris – What’s new? -

06/26/2015 - Pharmacological treatment of stable angina – Conventional and novel anti-anginal agents - Dr Amelia Carro Hevia, Corvilud Institute, Spain

No comments

+ Add a comment

Leave a Reply Cancel reply